202 related articles for article (PubMed ID: 9349507)
1. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs.
Knippschild U; Milne DM; Campbell LE; DeMaggio AJ; Christenson E; Hoekstra MF; Meek DW
Oncogene; 1997 Oct; 15(14):1727-36. PubMed ID: 9349507
[TBL] [Abstract][Full Text] [Related]
2. IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects.
Behrend L; Milne DM; Stöter M; Deppert W; Campbell LE; Meek DW; Knippschild U
Oncogene; 2000 Nov; 19(47):5303-13. PubMed ID: 11103931
[TBL] [Abstract][Full Text] [Related]
3. p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage.
Knippschild U; Milne D; Campbell L; Meek D
Oncogene; 1996 Oct; 13(7):1387-93. PubMed ID: 8875976
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme.
Milne DM; Palmer RH; Campbell DG; Meek DW
Oncogene; 1992 Jul; 7(7):1361-9. PubMed ID: 1620549
[TBL] [Abstract][Full Text] [Related]
5. Murine p53 is phosphorylated within the PAb421 epitope by protein kinase C in vitro, but not in vivo, even after stimulation with the phorbol ester o-tetradecanoylphorbol 13-acetate.
Milne DM; McKendrick L; Jardine LJ; Deacon E; Lord JM; Meek DW
Oncogene; 1996 Jul; 13(1):205-11. PubMed ID: 8700548
[TBL] [Abstract][Full Text] [Related]
6. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
Müller E; Boldyreff B; Scheidtmann KH
Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
[TBL] [Abstract][Full Text] [Related]
7. Association of casein kinase II with immunopurified p53.
Herrmann CP; Kraiss S; Montenarh M
Oncogene; 1991 May; 6(5):877-84. PubMed ID: 2052362
[TBL] [Abstract][Full Text] [Related]
8. The DNA-binding activity of mouse DNA methyltransferase 1 is regulated by phosphorylation with casein kinase 1delta/epsilon.
Sugiyama Y; Hatano N; Sueyoshi N; Suetake I; Tajima S; Kinoshita E; Kinoshita-Kikuta E; Koike T; Kameshita I
Biochem J; 2010 Apr; 427(3):489-97. PubMed ID: 20192920
[TBL] [Abstract][Full Text] [Related]
9. JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases.
Hu MC; Qiu WR; Wang YP
Oncogene; 1997 Nov; 15(19):2277-87. PubMed ID: 9393873
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo.
Giamas G; Hirner H; Shoshiashvili L; Grothey A; Gessert S; Kühl M; Henne-Bruns D; Vorgias CE; Knippschild U
Biochem J; 2007 Sep; 406(3):389-98. PubMed ID: 17594292
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of murine p53, but not human p53, by MAP kinase in vitro and in cultured cells highlights species-dependent variation in post-translational modification.
Jardine LJ; Milne DM; Dumaz N; Meek DW
Oncogene; 1999 Dec; 18(52):7602-7. PubMed ID: 10602521
[TBL] [Abstract][Full Text] [Related]
12. Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.
Rolley N; Milner J
Oncogene; 1994 Oct; 9(10):3067-70. PubMed ID: 8084615
[TBL] [Abstract][Full Text] [Related]
13. IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer.
Liu M; Hu Y; Lu S; Lu M; Li J; Chang H; Jia H; Zhou M; Ren F; Zhong J
Int J Biol Sci; 2020; 16(5):882-892. PubMed ID: 32071557
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic fragments of the Alzheimer's disease associated presenilins-1 and -2 are phosphorylated in vivo by distinct cellular mechanisms.
Walter J; Grünberg J; Schindzielorz A; Haass C
Biochemistry; 1998 Apr; 37(17):5961-7. PubMed ID: 9558331
[TBL] [Abstract][Full Text] [Related]
15. The human glutathione S-transferase P1 protein is phosphorylated and its metabolic function enhanced by the Ser/Thr protein kinases, cAMP-dependent protein kinase and protein kinase C, in glioblastoma cells.
Lo HW; Antoun GR; Ali-Osman F
Cancer Res; 2004 Dec; 64(24):9131-8. PubMed ID: 15604283
[TBL] [Abstract][Full Text] [Related]
16. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
Nip J; Hiebert SW
Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
[TBL] [Abstract][Full Text] [Related]
18. Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450.
Sillibourne JE; Milne DM; Takahashi M; Ono Y; Meek DW
J Mol Biol; 2002 Sep; 322(4):785-97. PubMed ID: 12270714
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 signals ARF-dependent stabilization and coactivation of p53.
Somasundaram K; MacLachlan TK; Burns TF; Sgagias M; Cowan KH; Weber BL; el-Deiry WS
Oncogene; 1999 Nov; 18(47):6605-14. PubMed ID: 10597265
[TBL] [Abstract][Full Text] [Related]
20. Association of CPI-17 with protein kinase C and casein kinase I.
Zemlickova E; Johannes FJ; Aitken A; Dubois T
Biochem Biophys Res Commun; 2004 Mar; 316(1):39-47. PubMed ID: 15003508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
